Trial Profile
Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IMA-026 Administered Subcutaneously or Intravenously to Healthy Japanese Male Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Jul 2009
Price :
$35
*
At a glance
- Drugs IMA 026 (Primary) ; IMA 026 (Primary)
- Indications Asthma
- Focus Adverse reactions; Pharmacokinetics
- 24 Jul 2009 Actual end date (Nov 2008) added as reported by ClinicalTrials.gov.
- 22 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jul 2008 New trial record.